INSM
Insmed Inc
121.60$
+2.7%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.4% | -12.8% | +56.2% | +13.4% | -1.4% | -11.0% | +37.6% | -4.8% | -4.1% | -8.3% | +1.3% | |
| – | +0.3% | -18.3% | +86.9% | +16.3% | -1.7% | -13.5% | +48.4% | -7.2% | -7.1% | -10.1% | +1.3% | |
| – | -1.0% | +23.5% | +109.3% | -63.0% | +20.3% | -27.3% | +218.5% | -73.9% | +52.5% | +14.1% | -6.4% | |
| – | -0.7% | -23.7% | +109.3% | +17.7% | -2.3% | -16.3% | +54.8% | -9.5% | -14.9% | -14.4% | -5.2% | |
| – | +15.8% | -9.8% | +8.4% | +5.0% | +22.9% | -8.2% | +15.3% | +18.6% | +115.8% | +26.8% | +20.6% | |
| – | +6.8% | -0.3% | +8.6% | +9.3% | +0.1% | +2.2% | +6.8% | +12.4% | +9.2% | +0.6% | +7.1% | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | -1.9% | -2.0% | -2.0% | -2.1% | -2.1% | -2.2% | -2.2% | +50.7% | +15.4% | -2.1% | -2.2% | |
| – | +2.9% | -2.3% | +9.1% | -11.4% | +10.8% | -2.1% | -27.8% | +15.0% | +7.8% | -10.1% | -1.9% | |
| – | +14.7% | +86.5% | +24.5% | -50.6% | +14.8% | -19.6% | +30.3% | +33.9% | +12.4% | -23.0% | +21.5% | |
| – | +56.4% | +1,576.4% | +1.0% | -94.0% | +15.9% | -37.7% | +6.7% | +12.4% | +56.4% | -25.1% | -32.0% | |
| – | +0.0% | -32.7% | +16.7% | +26.5% | +12.4% | -21.0% | +28.4% | +7.5% | +0.4% | -8.2% | +484.5% | |
| – | +0.7% | -18.7% | +0.8% | +0.8% | +15.6% | +0.2% | -51.3% | +0.2% | +0.2% | +0.2% | +0.2% | |
| – | – | – | – | +1,145.3% | -41.0% | -65.3% | +1,160.3% | -24.3% | -21.8% | -4.6% | +7.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1.3% | +2.5% | +4.2% | +12.3% | +3.1% | +1.0% | +4.7% | +11.7% | +1.0% | +0.9% | +0.9% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.